Sayana Press (DMPA-SC in Uniject) Clinical Brief
This brief provides a clinical overview of the injectable contraceptive subcutaneous DMPA (DMPA-SC or Sayana® Press), which contains 30% less depot medroxyprogesterone acetate than the intramuscular presentation of Depo-Provera®. DMPA-SC is administered subcutaneously through the prefilled Uniject injection system, an autodisable injection device. For more information, visit www.path.org/dmpa-sc, sign up for our newsletter, or email FPoptions@path.org.
Publication date: March 2017
Available materials
-
English
-
French